Based on the limitations of serum PSA evaluations alone to provide meaningful insight into prostate cancer detection, Thompson et al. suggested that “PSA levels should no longer be referred to as “normal” or “elevated” but should be incorporated into a multivariable risk assessment to provide individualized risk information for decision making”.41 Here, KLK3 is linked to prostate carcinoma.